ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
8.37
+0.02 (0.24%)
At close: Jan 22, 2026
ZIVO Bioscience Revenue
ZIVO Bioscience had revenue of $65.63K in the quarter ending September 30, 2025, with 108.33% growth. This brings the company's revenue in the last twelve months to $209.03K, up 164.52% year-over-year. In the year 2024, ZIVO Bioscience had annual revenue of $157.22K with 468.61% growth.
Revenue (ttm)
209.03K
Revenue Growth
+164.52%
P/S Ratio
158.20
Revenue / Employee
29.86K
Employees
7
Market Cap
33.07M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 157.22K | 129.57K | 468.61% |
| Dec 31, 2023 | 27.65K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 20.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| LakeShore Biopharma | 84.75M |
| Zeo ScientifiX | 4.79M |
| Harvard Apparatus Regenerative Technology | 743.00K |
| Provectus Biopharmaceuticals | 350.44K |
| Ayala Pharmaceuticals | 13.00K |
| Arch Biopartners | -62.11K |
ZIVO Bioscience News
- 3 months ago - Insider Buying: Christopher Maggiore Acquires Additional Shares of Zivo Bioscience Inc (ZIVO) - GuruFocus
- 4 months ago - ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses - Business Wire
- 7 months ago - ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry - Business Wire
- 9 months ago - University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry - Business Wire
- 1 year ago - ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry - Business Wire
- 1 year ago - ZIVO Bioscience to Present at The Microcap Conference 2025 - Business Wire
- 1 year ago - ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities - Business Wire
- 1 year ago - ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza - Business Wire